As Gink­go looks to clear its name, the feds have come sniff­ing around on the heels of short sell re­port

A month and a half af­ter a short sell at­tack near­ly brought Gink­go Bioworks’ new­ly pub­lic shares to its knees, the com­pa­ny on Mon­day took its largest step to date to­ward clear­ing its name. But it al­so re­vealed it’s cur­rent­ly the tar­get of a De­part­ment of Jus­tice probe.

Gink­go re­ceived an “in­for­mal in­quiry” from the DOJ con­nect­ed to the short sell re­port, re­leased last month by hedge fund Scor­pi­on Cap­i­tal, the com­pa­ny said dur­ing Mon­day’s third quar­ter earn­ings call. CEO Ja­son Kel­ly told an­a­lysts Gink­go is “co­op­er­at­ing” with reg­u­la­tors, sug­gest­ing the in­ves­ti­ga­tion re­mains on­go­ing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER